Diagnosis of Pleural Tuberculosis

Characteristics of Pleural Fluid in Tuberculosis

• The pleural fluid in tuberculosis is typically an exudate with a predominance of lymphocytes, but this characteristic is not exclusive to tuberculosis 1
• Acid-fast bacillus stains in pleural fluid are positive in only 10-20% of cases of pleural tuberculosis 1

Diagnostic Methods

• Pleural biopsy sent for both histological examination and culture improves the diagnostic rate to approximately 90% 1, 2
• Determination of adenosine deaminase (ADA) in pleural fluid is useful, with levels above 40-47 U/L highly suggestive of tuberculosis in lymphocytic effusions 1
• However, high levels of ADA can also be found in empyemas, rheumatoid pleuritis, and some neoplasias, which reduces its utility in countries with low prevalence of tuberculosis 1

Special Considerations

• In patients with HIV, the three main causes of pleural effusion are Kaposi's sarcoma, parapneumonic effusions, and tuberculosis 3, 4

Diagnostic Algorithm

• In the presence of a lymphocytic exudative pleural effusion, ADA should be requested in pleural fluid 1
• If ADA is >40 U/L in a compatible clinical context and in an area of high tuberculosis prevalence, consider starting empirical antitubercular treatment 3
• In doubtful cases or in areas of low prevalence, pleural biopsy should be performed for histological study and culture 1, 2

Differential Diagnosis

• In cases of persistent undiagnosed pleural effusions, always reconsider tuberculosis and pulmonary embolism, as they are treatable disorders 3, 5
• Other common causes of pleural effusion include heart failure (29%), neoplasms (26%), pneumonia (16%), tuberculosis (6%), post-surgical (4%), pericardial diseases (4%), and cirrhosis (3%) 4
• In patients with HIV, also consider Kaposi's sarcoma (one-third of cases), parapneumonic effusions (28%), Pneumocystis carinii pneumonia (10%), and lymphoma (7%) 6

Diagnosing Tuberculous Pleural Effusion

Cutoff Values and Diagnostic Approach

• The American Thoracic Society suggests using ADA primarily as an exclusion test rather than a diagnostic test in low to medium prevalence populations, with a cutoff of 41.5 U/L providing 97.1% sensitivity and 92.9% specificity 7
• The British Thoracic Society recommends obtaining tissue sampling for culture and sensitivity as the preferred diagnostic method, even when ADA is elevated, as stated in the Thorax journal 7

Performance Characteristics and Clinical Algorithm

Complementary Testing

Diagnostic Approach to Tuberculous Pleural Effusion

Introduction to Diagnostic Markers

• Adenosine deaminase (ADA) is the most commonly used pleural fluid marker for diagnosing tuberculous pleural effusion, with interferon-gamma (IFN-γ) offering even higher diagnostic accuracy when available, as recommended by the American Thoracic Society 8, 9

Diagnostic Algorithm

• In high TB prevalence areas, consider empirical antitubercular treatment if ADA >40 U/L with compatible clinical context, and add IFN-γ testing for enhanced diagnostic certainty if available, as suggested by the European Respiratory Society 8, 9
• In low TB prevalence areas, use ADA primarily to exclude tuberculosis, with a high negative predictive value of 97.9%, as recommended by the Centers for Disease Control and Prevention 8, 9

Tissue Confirmation and Diagnostic Approach

• Tissue sampling for culture and sensitivity remains the preferred diagnostic approach for all patients with suspected tuberculous pleural effusion, regardless of ADA results, with a strong recommendation by consensus from the World Health Organization 8, 9

Limitations of Biomarkers

• Serum biomarkers should not routinely be used for diagnosing tuberculous pleural effusion, though may be considered in high prevalence areas, as stated by the American College of Chest Physicians 8, 9
• Pleural fluid biomarkers other than ADA and IFN-γ lack sufficient evidence for routine clinical use, according to the National Institute for Health and Care Excellence 8, 9

Diagnostic Approach to Tuberculous Pleural Effusion in Adolescents

Initial Pleural Fluid Evaluation

• Send all aspirated pleural fluid for a differential cell count; this is mandatory for every case. 10
• Tuberculous effusions most often show a lymphocyte‑predominant exudate, but approximately 10 % can be neutrophil‑predominant, so a neutrophilic pattern does not exclude tuberculosis. 10
• A lymphocyte‑predominant exudate should raise suspicion for tuberculosis or malignancy and trigger further diagnostic work‑up. 10

Microbiological Testing of Pleural Fluid

• Submit pleural fluid for acid‑fast bacilli (AFB) staining, mycobacterial culture, and M. tuberculosis PCR to maximize diagnostic yield. 10
• PCR of pleural fluid has low sensitivity but delivers results more rapidly than conventional culture, aiding early decision‑making. 10
• Placing pleural fluid into anaerobic blood‑culture bottles before transport improves mycobacterial recovery rates. 10

Adjunctive Non‑invasive Tests

• Perform a Mantoux (tuberculin skin) test when the fluid is lymphocyte‑rich and the clinical history is compatible with tuberculosis exposure. 10
• Thoracic ultrasound can reveal pleural thickening and diffuse small nodules on the pleural surface, findings that are suggestive of tuberculous involvement. 11

Tissue Diagnosis When Fluid Studies Are Inconclusive

• If the diagnosis remains uncertain—particularly in low‑prevalence settings—obtain a pleural biopsy for histology and culture to increase diagnostic certainty. 10

Procedural and Clinical Pitfalls

• Do not rely solely on routine biochemical analyses (pH, glucose, LDH) for diagnosing tuberculous pleural effusion in adolescents; these parameters are not informative for this condition. 10
• Do not assume that every lymphocyte‑predominant effusion is due to tuberculosis; systematic evaluation for malignancy is required, especially when the fluid is blood‑stained or shows atypical features. 10
• Avoid large‑volume thoracentesis and general anesthesia in patients with a mediastinal mass or significant lymphadenopathy, as these maneuvers carry a high risk of mortality. 12
• Remember that about 10 % of tuberculous pleural effusions are neutrophil‑predominant; therefore, a neutrophilic cell count should not be used to exclude tuberculosis. 10

Diagnostic Evaluation of Tuberculous Pleural Effusion

ADA Testing Performance

• Pleural fluid adenosine deaminase (ADA) > 40–45 U/L provides 91 % sensitivity and 88 % specificity for tuberculous pleural effusion (meta‑analysis of 24 studies). 13
• Using an ADA cutoff > 45 U/L yields 91 % sensitivity (95 % CI 87–93 %) and 88 % specificity (95 % CI 86–93 %) across 24 studies. 13

Guideline Endorsements

• The British Thoracic Society and the ATS/IDSA/CDC guidelines recommend measuring pleural fluid ADA in patients with suspected tuberculous pleural effusion. 13, 14, 15
• The British Thoracic Society strongly recommends pleural tissue sampling for culture and drug‑susceptibility testing as the preferred diagnostic approach for all suspected tuberculous pleural effusions. 13

Comparative Performance of Culture and Smear

• Acid‑fast bacilli (AFB) culture of pleural fluid shows 23 %–58 % sensitivity but high specificity, limiting its usefulness as a sole diagnostic test. 16, 14
• Mycobacterial culture provides a definitive diagnosis and enables drug‑susceptibility testing, capabilities that ADA measurement cannot replace. 16, 14
• AFB smear of pleural fluid has 0 %–10 % sensitivity and 100 % specificity when positive, indicating very low sensitivity but perfect specificity. 16, 14

Adjunctive Interferon‑γ Testing

• Pleural fluid interferon‑γ testing demonstrates 95 % sensitivity and 96 % specificity, offering enhanced diagnostic certainty when available. 13, 15

Clinical Application in Different Prevalence Settings

• In low‑TB‑prevalence areas, an ADA level < 40 U/L yields a negative predictive value of 97.9 %, effectively ruling out tuberculous pleural effusion. 13